Omega Therapeutics, Inc.
0.0621USDD
−0.0002−0.32%
At close at Jul 16, 19:59 GMT
USD
No trades
54.45 M
About Omega Therapeutics, Inc.
Sector
Industry
CEO
Kaan Certel
Website
Headquarters
Cambridge
Founded
2016
FIGI
BBG011R6NSW1
Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.
Related stocks
ELAB
PMGC Holdings Inc.RMarket closed
2.37USD+3.49%
AQB
AquaBounty Technologies, Inc.RMarket closed
0.7831USD+0.38%
CPMV
Mosaic ImmunoEngineering Inc.DMarket closed
0.4135USD+2.21%
ADTX
Aditxt, Inc.RMarket closed
1.19USD+2.15%
ENZC
Enzolytics Inc.DMarket closed
0.0007USD−12.50%
APDN
Applied DNA Sciences, Inc.RMarket closed
5.03USD+1.00%
SXTP
60 Degrees Pharmaceuticals, Inc.RMarket closed
1.64USD−6.29%
VCNX
Vaccinex, Inc.DMarket closed
0.8700USD−11.12%
−880%
−810%
−740%
−670%
−600%
Q1 '24
Q2 '24
Q3 '24
−21.00 M
−14.00 M
−7.00 M
0.00
7.00 M
Revenue
Net income
Net margin %
No data available
There's currently no revenue data to show for the selected period.
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−50.00 M
0.00
50.00 M
100.00 M
150.00 M
Debt
Free cash flow
Cash & equivalents
No news here
Looks like there's nothing to report right now
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of OMGAQ is 0.0621 USD — it has decreased by −0.32% in the past 24 hours. Watch Omega Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Omega Therapeutics, Inc. stocks are traded under the ticker OMGAQ.
OMGAQ stock has fallen by −4.46% compared to the previous week, the month change is a 121.79% rise, over the last year Omega Therapeutics, Inc. has showed a −96.83% decrease.
OMGAQ reached its all-time high on Nov 1, 2021 with the price of 31.4100 USD, and its all-time low was 0.0100 USD and was reached on Mar 7, 2025. View more price dynamics on OMGAQ chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
OMGAQ stock is 93.91% volatile and has beta coefficient of 2.38. Track Omega Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Omega Therapeutics, Inc. there?
Today Omega Therapeutics, Inc. has the market capitalization of 3.45 M, it has increased by 83.48% over the last week.
Yes, you can track Omega Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
No, OMGAQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OMGAQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Omega Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Omega Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Omega Therapeutics, Inc. stock shows the sell signal. See more of Omega Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.